Chronic Obstructive Pulmonary Disease: Clinical Trials

5 trials for Chronic Obstructive Pulmonary Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 withdrawn. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Withdrawn 5
Phase 11Withdrawn 1

Follow Chronic Obstructive Pulmonary Disease: new trials by email Literature Review of Chronic Obstructive Pulmonary Disease trials Research Report on Chronic Obstructive Pulmonary Disease

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
Biospecimen Collection, Bronchial Brush Biopsy, Bronchoscopy - Bronchial Epithelial Dysplasia, Chronic Obstructive Pulmonary Disease
Phase 2WithdrawnNational Cancer Institute (NCI)2024-06-012024-05-17
The Multicenter Topic Trial
Ivacaftor - Chronic Obstructive Pulmonary Disease
Phase 2WithdrawnUniversity of Alabama at Birmingham2021-12-012022-01-27
Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
Inhaled Treprostinil - Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease
Phase 2WithdrawnUnited Therapeutics2017-04-012017-04-11
A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease
Tiotropium HFA BAI 5 mcg, Tiotropium 18 mcg Capsule, Placebo - Chronic Obstructive Pulmonary Disease, COPD
Phase 2WithdrawnTeva Branded Pharmaceutical Products R&D, Inc.2014-08-012021-11-09
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
Lipoaspiration with Local anesthesia - Chronic Obstructive Pulmonary Disease
Phase 1 / Phase 2WithdrawnAgeless Regenerative Institute2014-03-012017-11-24

Narrower conditions

Pulmonary Disease, Chronic Obstructive (5)  ·  Hypertension, Pulmonary (1)  ·  Lung Neoplasms (1)

Broader conditions

Chronic Disease (5)  ·  Disease Attributes (5)  ·  Lung Diseases (5)  ·  Lung Diseases, Obstructive (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Respiratory Tract Diseases (5)  ·  Cardiovascular Diseases (1)  ·  Hypertension (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)  ·  Vascular Diseases (1)

Interventions

Anesthesia, Local (1)  ·  Bronchoscopy (1)  ·  Iloprost (1)  ·  Lipectomy (1)  ·  Specimen Handling (1)  ·  Tiotropium Bromide (1)  ·  ivacaftor (1)  ·  treprostinil (1)

Sponsors

Ageless Regenerative Institute (1)  ·  National Cancer Institute (NCI) (1)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (1)  ·  United Therapeutics (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (1)

Top investigators

Mark Dransfield, MD (1)  ·  Sharon McQuillan, MD (1)  ·  York E Miller (1)

NIH funding

P30CA060553 (1), P30DK072482 (1), UG1CA242643 (1)